Search research articles
Contact Us
Filters
Showing results (111-120 of 150) with videos related to
Page
of 15
Sort By:
Journal of Surgical Oncology
|
August 1, 1983
Surgery in patients with advanced germ cell malignancy following a clinical partial response to chemotherapy
R R Reddel, J F Thompson, D Raghavan, et al.
Breast Cancer Research and Treatment
|
April 28, 2019
Dose intensity in anthracycline-based chemotherapy for metastatic breast cancer: mature results of the randomised clinical trial ANZ 9311
Stephen P Ackland, V Gebski, N Zdenkowski, et al.
Cancer Treatment Reports
|
July 1, 1984
Mitolactol chemotherapy for malignant melanoma: a phase II study
L T Malden, A S Coates, G W Milton, et al.
British Journal of Cancer
|
April 26, 2012
Subjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancer
K Ribi, J Aldridge, K-A Phillips, et al.
Lancet (London, England)
|
May 11, 1996
Impact of adjuvant therapy on quality of life in women with node-positive operable breast cancer. International Breast Cancer Study Group
C Hürny, J Bernhard, A S Coates, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 27, 2009
The effect of endocrine responsiveness on high-risk breast cancer treated with dose-intensive chemotherapy: results of International Breast Cancer Study Group Trial 15-95 after prolonged follow-up
M Colleoni, Z Sun, G Martinelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 2, 2000
Early start of adjuvant chemotherapy may improve treatment outcome for premenopausal breast cancer patients with tumors not expressing estrogen receptors. The International Breast Cancer Study Group
M Colleoni, M Bonetti, A S Coates, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 29, 2020
The legacy of Professor Aron Goldhirsch
R D Gelber, A S Coates, S Gelber, et al.
British Journal of Cancer
|
September 23, 1998
Factors affecting baseline quality of life in two international adjuvant breast cancer trials. International Breast Cancer Study Group (IBCSG)
J Bernhard, C Hürny, A S Coates, et al.
Lancet (London, England)
|
June 24, 2000
Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?
S Aebi, S Gelber, M Castiglione-Gertsch, et al.
Page
of 15
Search research articles
Search
Showing results (111-120 of 150) with videos related to
Sort By:
Page
of 15
Journal of Surgical Oncology
|
August 1, 1983
Surgery in patients with advanced germ cell malignancy following a clinical partial response to chemotherapy
R R Reddel, J F Thompson, D Raghavan, et al.
Breast Cancer Research and Treatment
|
April 28, 2019
Dose intensity in anthracycline-based chemotherapy for metastatic breast cancer: mature results of the randomised clinical trial ANZ 9311
Stephen P Ackland, V Gebski, N Zdenkowski, et al.
Cancer Treatment Reports
|
July 1, 1984
Mitolactol chemotherapy for malignant melanoma: a phase II study
L T Malden, A S Coates, G W Milton, et al.
British Journal of Cancer
|
April 26, 2012
Subjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancer
K Ribi, J Aldridge, K-A Phillips, et al.
Lancet (London, England)
|
May 11, 1996
Impact of adjuvant therapy on quality of life in women with node-positive operable breast cancer. International Breast Cancer Study Group
C Hürny, J Bernhard, A S Coates, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 27, 2009
The effect of endocrine responsiveness on high-risk breast cancer treated with dose-intensive chemotherapy: results of International Breast Cancer Study Group Trial 15-95 after prolonged follow-up
M Colleoni, Z Sun, G Martinelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 2, 2000
Early start of adjuvant chemotherapy may improve treatment outcome for premenopausal breast cancer patients with tumors not expressing estrogen receptors. The International Breast Cancer Study Group
M Colleoni, M Bonetti, A S Coates, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 29, 2020
The legacy of Professor Aron Goldhirsch
R D Gelber, A S Coates, S Gelber, et al.
British Journal of Cancer
|
September 23, 1998
Factors affecting baseline quality of life in two international adjuvant breast cancer trials. International Breast Cancer Study Group (IBCSG)
J Bernhard, C Hürny, A S Coates, et al.
Lancet (London, England)
|
June 24, 2000
Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?
S Aebi, S Gelber, M Castiglione-Gertsch, et al.
Page
of 15